AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35148973 — intervention group
Group type: EXPERIMENTAL
Intervention: Micro-osteoperforation (MOP)
Number of subjects: 20
Study 34088505 — intervention group
Group type: EXPERIMENTAL
Intervention: FD-subunit NAIIV4
Number of subjects: 320
Study 34088505 — intervention group
Group type: COMPARATOR
Intervention: split-virion NAIIV4 (active control)
Number of subjects: 320
Study 34088505 — intervention group
Group type: COMPARATOR
Intervention: HD-subunit NAIIV4 (control)
Number of subjects: 320
Study 32205684 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural Fentanyl and Bupivacaine (10-mL solution of 50 mcg of Fentanyl, 0.125% Bupivacaine, and 0.9% saline solution)
Number of subjects: 45
Study 32205684 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural Fentanyl and Bupivacaine
Number of subjects: 45
Study 32205684 — intervention group
Group type: COMPARATOR
Intervention: Control group (decompression alone)
Number of subjects: 45
Study 36035303 — intervention group
Group type: EXPERIMENTAL
Intervention: CICARE communication model nursing intervention
Number of subjects: 102
Study 36035303 — intervention group
Group type: COMPARATOR
Intervention: Routine doctor-patient communication nursing
Number of subjects: 102
Study 34706426 — intervention group
Group type: EXPERIMENTAL
Intervention: ICD-11 guidelines
Number of subjects: 1357
Study 34706426 — intervention group
Group type: COMPARATOR
Intervention: ICD-10 guidelines
Number of subjects: 1357
Study 32628554 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Dose Rivaroxaban plus Aspirin
Number of subjects: 0
Study 32628554 — intervention group
Group type: COMPARATOR
Intervention: Aspirin
Number of subjects: 0
Study 35758984 — intervention group
Group type: EXPERIMENTAL
Intervention: Creative expression program (intervention)
Number of subjects: 120
Study 35758984 — intervention group
Group type: COMPARATOR
Intervention: Education as usual (control)
Number of subjects: 120
Study 34376181 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-component intervention (phone consultations, interactive phone application, pedometers)
Number of subjects: 375
Study 34376181 — intervention group
Group type: COMPARATOR
Intervention: Usual diabetes care
Number of subjects: 375
Study 34376181 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-component intervention
Number of subjects: 375
Study 35322396 — intervention group
Group type: EXPERIMENTAL
Intervention: Early rhythm control
Number of subjects: 62649
Study 35322396 — intervention group
Group type: EXPERIMENTAL
Intervention: Early rhythm control (performed early <3 months)
Number of subjects: 62649
Study 35322396 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 62649
Study 32960053 — intervention group
Group type: EXPERIMENTAL
Intervention: BAY 1214784, an orally available spiroindoline derivative, administered once daily
Number of subjects: 0
Study 32996592 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral treatment with telapristone acetate (12 mg/day)
Number of subjects: 60
Study 34241896 — intervention group
Group type: EXPERIMENTAL
Intervention: IANB + LLLT
Number of subjects: 88
Study 34241896 — intervention group
Group type: COMPARATOR
Intervention: IANB
Number of subjects: 88
Study 35550584 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower-energy swaps offered
Number of subjects: 2150
Study 35550584 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower-energy swaps offered with PACE information
Number of subjects: 2150
Study 32609979 — intervention group
Group type: EXPERIMENTAL
Intervention: Amoxicillin for 3 days
Number of subjects: 3000
Study 32609979 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin for 5 days
Number of subjects: 3000
Study 32609979 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 3000
Study 33735146 — intervention group
Group type: EXPERIMENTAL
Intervention: MUSTCOOL cooling patch
Number of subjects: 140
Study 33735146 — intervention group
Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 140
Study 32073955 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensity-Modulated Radiotherapy (IMRT)
Number of subjects: 234
Study 34219356 — intervention group
Group type: EXPERIMENTAL
Intervention: External hexagon connection (EHC)
Number of subjects: 20
Study 34219356 — intervention group
Group type: COMPARATOR
Intervention: Internal hexagon connection (IHC)
Number of subjects: 20
Study 33031356 — intervention group
Group type: EXPERIMENTAL
Intervention: lncRNAs in PD patients
Number of subjects: 55
Study 33031356 — intervention group
Group type: COMPARATOR
Intervention: lncRNAs in healthy volunteers (controls)
Number of subjects: 55
Study 36289399 — intervention group
Group type: EXPERIMENTAL
Intervention: Bamlanivimab 700 mg
Number of subjects: 271
Study 36289399 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 271
Study 36289399 — intervention group
Group type: EXPERIMENTAL
Intervention: Bamlanivimab 7,000 mg
Number of subjects: 271
Study 33882026 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-domain lifestyle interventions (6-month duration physical exercise, nutritional enrichment, cognitive training)
Number of subjects: 246
Study 33882026 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-domain lifestyle interventions
Number of subjects: 246
Study 33882026 — intervention group
Group type: EXPERIMENTAL
Intervention: Active intervention
Number of subjects: 246
Study 33882026 — intervention group
Group type: COMPARATOR
Intervention: Standard care control
Number of subjects: 246
Study 32194255 — intervention group
Group type: EXPERIMENTAL
Intervention: Low pressure pneumoperitoneum (8 mmHg)
Number of subjects: 30
Study 32194255 — intervention group
Group type: COMPARATOR
Intervention: Standard pressure pneumoperitoneum (12 and 16 mmHg)
Number of subjects: 30
Study 35002538 — intervention group
Group type: EXPERIMENTAL
Intervention: Wrist-ankle acupuncture-moxibustion and hot compression with Chinese herbal medicine
Number of subjects: 82
Study 35002538 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment
Number of subjects: 82
Study 32301992 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiovascular RCTs with multiplicity adjustment
Number of subjects: 511
Study 32301992 — intervention group
Group type: COMPARATOR
Intervention: Cardiovascular RCTs without multiplicity adjustment
Number of subjects: 511
Study 32301992 — intervention group
Group type: EXPERIMENTAL
Intervention: Trials assessing mortality outcomes
Number of subjects: 511
Study 32301992 — intervention group
Group type: COMPARATOR
Intervention: Trials assessing nonmortality outcomes
Number of subjects: 511
Study 32301992 — intervention group
Group type: EXPERIMENTAL
Intervention: Larger trials
Number of subjects: 511
Study 32301992 — intervention group
Group type: COMPARATOR
Intervention: Smaller trials
Number of subjects: 511
Study 32161004 — intervention group
Group type: EXPERIMENTAL
Intervention: cMNV3
Number of subjects: 102
Study 32161004 — intervention group
Group type: COMPARATOR
Intervention: usual MNV3 without CRA
Number of subjects: 102
Study 32532310 — intervention group
Group type: EXPERIMENTAL
Intervention: Ropivacaine 75 mg
Number of subjects: 272
Study 32532310 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 272
Study 35457744 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight Watchers® Momentum™ (WW)
Number of subjects: 51
Study 35457744 — intervention group
Group type: COMPARATOR
Intervention: Curves® (CV) Fitness and Weight Management program
Number of subjects: 51
Study 35457744 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 51
Study 34474192 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy-restricted Mediterranean Diet (er-MedDiet)
Number of subjects: 487
Study 35125048 — intervention group
Group type: EXPERIMENTAL
Intervention: Total thoracic echogenicity intensity score (TTEI)
Number of subjects: 29
Study 34255381 — intervention group
Group type: EXPERIMENTAL
Intervention: elbasvir/grazoprevir (EBR/GZR)
Number of subjects: 1609
Study 34255381 — intervention group
Group type: EXPERIMENTAL
Intervention: ledipasvir/sofosbuvir (LDV/SOF)
Number of subjects: 1609
Study 34255381 — intervention group
Group type: COMPARATOR
Intervention: Both EBR/GZR and LDV/SOF
Number of subjects: 1609
Study 35999521 — intervention group
Group type: EXPERIMENTAL
Intervention: Flash dose of preoperative corticosteroids
Number of subjects: 1200
Study 35999521 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1200
Study 34159691 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio taping (KT) with exercise
Number of subjects: 88
Study 34159691 — intervention group
Group type: EXPERIMENTAL
Intervention: Dry needling (DN) with exercise
Number of subjects: 88
Study 34159691 — intervention group
Group type: COMPARATOR
Intervention: Control group (exercise only)
Number of subjects: 88
Study 33361239 — intervention group
Group type: EXPERIMENTAL
Intervention: Sharing Histories (SH) training method for community health workers (CHWs)
Number of subjects: 606
Study 33361239 — intervention group
Group type: COMPARATOR
Intervention: Standard training methods for community health workers (CHWs)
Number of subjects: 606
Study 32350819 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural grazing resources available during summer
Number of subjects: 63
Study 32350819 — intervention group
Group type: EXPERIMENTAL
Intervention: Concentrate feed supplementation (86%) and tree foliage (92%) during winter
Number of subjects: 63
Study 32350819 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-prepared concentrate feed by 87% of farmers
Number of subjects: 63
Study 32350819 — intervention group
Group type: EXPERIMENTAL
Intervention: Mineral mixture supplementation (6%)
Number of subjects: 63
Study 32350819 — intervention group
Group type: EXPERIMENTAL
Intervention: Lack of technical know-how and winter feed scarcity
Number of subjects: 63
Study 32350819 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutritional innovations and fodder conservation strategies suggested
Number of subjects: 63
Study 35821536 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intervention (18 nutritionist-led group sessions in the first year, then quarterly sessions throughout 8.5 years)
Number of subjects: 48535
Study 35821536 — intervention group
Group type: COMPARATOR
Intervention: Usual diet comparison (written health-related materials only)
Number of subjects: 48535
Study 32641470 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen sodium 440 mg
Number of subjects: 80
Study 32641470 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen sodium 220 mg
Number of subjects: 80
Study 32641470 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study 32641470 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen (both doses)
Number of subjects: 80
Study 34809970 — intervention group
Group type: EXPERIMENTAL
Intervention: Myocardial injury after noncardiac surgery
Number of subjects: 394
Study 34809970 — intervention group
Group type: COMPARATOR
Intervention: Prolonged surgery
Number of subjects: 394
Study 34809970 — intervention group
Group type: COMPARATOR
Intervention: Need for transfusions
Number of subjects: 394
Study 34809970 — intervention group
Group type: COMPARATOR
Intervention: Major adverse cardiac events
Number of subjects: 394
Study 34809970 — intervention group
Group type: COMPARATOR
Intervention: Pulmonary complications
Number of subjects: 394
Study 34809970 — intervention group
Group type: COMPARATOR
Intervention: Acute kidney injury
Number of subjects: 394
Study 34809970 — intervention group
Group type: COMPARATOR
Intervention: Systemic inflammatory syndrome
Number of subjects: 394
Study 34809970 — intervention group
Group type: EXPERIMENTAL
Intervention: Survival up to 30 months after surgery
Number of subjects: 394
Study 34582452 — intervention group
Group type: EXPERIMENTAL
Intervention: Antenatal malaria exposure (positive: 240 [57.3%])
Number of subjects: 421
Study 34582452 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal immune activation (increased maternal sTNFRII concentration)
Number of subjects: 421
Study 35713449 — intervention group
Group type: EXPERIMENTAL
Intervention: Nalbuphine in patient-controlled intravenous analgesia
Number of subjects: 0
Study 35713449 — intervention group
Group type: COMPARATOR
Intervention: Sufentanil
Number of subjects: 0
Study 32427667 — intervention group
Group type: EXPERIMENTAL
Intervention: Social support for overcoming treatment-related challenges
Number of subjects: 8
Study 32427667 — intervention group
Group type: EXPERIMENTAL
Intervention: Racial differences in support needs and provision
Number of subjects: 8
Study 32427667 — intervention group
Group type: EXPERIMENTAL
Intervention: Resources within individual support networks
Number of subjects: 8
Study 32427667 — intervention group
Group type: EXPERIMENTAL
Intervention: Reliance on family/friends for cancer care
Number of subjects: 8
Study 35871728 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram predictive model for overall survival (OS) and cancer-specific survival (CSS) based on 5 variables: age, gender, WHO grades, surgery, and radiotherapy.
Number of subjects: 369
Study 35871728 — intervention group
Group type: EXPERIMENTAL
Intervention: Nomogram predictive model for OS and CSS in validation cohort.
Number of subjects: 369
Study 35871728 — intervention group
Group type: EXPERIMENTAL
Intervention: Calibration plots for OS and CSS.
Number of subjects: 369
Study 34039479 — intervention group
Group type: EXPERIMENTAL
Intervention: Open-label trial for vaccination
Number of subjects: 0
Study 34039479 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonrandomized trial for parents willing to vaccinate their children
Number of subjects: 0
Study 34039479 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonrandomized trial for parents hesitant to vaccinate their children
Number of subjects: 0
Study 32887707 — intervention group
Group type: EXPERIMENTAL
Intervention: Sensor-augmented insulin pump therapy (SAP) for 1 year
Number of subjects: 26
Study 32887707 — intervention group
Group type: COMPARATOR
Intervention: Control group (multiple daily injection therapy)
Number of subjects: 26
Study 36241128 — intervention group
Group type: EXPERIMENTAL
Intervention: eRAPID (weekly online symptom reporting for 12, 18 & 24 weeks)
Number of subjects: 167
Study 36241128 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 167
Study 33914556 — intervention group
Group type: COMPARATOR
Intervention: Control writing condition
Number of subjects: 100
Study 34755130 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral immunotherapy (OIT)
Number of subjects: 0
Study 34755130 — intervention group
Group type: EXPERIMENTAL
Intervention: OIT
Number of subjects: 0
Study 32568096 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosuvastatin (40 mg loading dose)
Number of subjects: 125
Study 32568096 — intervention group
Group type: COMPARATOR
Intervention: Control (no statin)
Number of subjects: 125
Study 34319247 — intervention group
Group type: EXPERIMENTAL
Intervention: SMS text messaging intervention (daily for the first 4 weeks, 5 messages on week 5, 3 messages each in weeks 6 and 7, and 1 message weekly from week 8 to week 52)
Number of subjects: 930
Study 34319247 — intervention group
Group type: COMPARATOR
Intervention: Control group (monthly SMS text message reminding of next study appointment and importance of the study)
Number of subjects: 930
Study 32155825 — intervention group
Group type: EXPERIMENTAL
Intervention: Sorafenib and nutrient-restriction
Number of subjects: 0
Study 32155825 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent fasting with sorafenib
Number of subjects: 0
Study 32155825 — intervention group
Group type: COMPARATOR
Intervention: Chloroquine with nutrient-restriction/sorafenib
Number of subjects: 0
Study 35579641 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcatheter Aortic Valve Implantation (TAVI)
Number of subjects: 913
Study 35579641 — intervention group
Group type: COMPARATOR
Intervention: Surgical Aortic Valve Replacement (surgery)
Number of subjects: 913
Study 33664081 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.375‐4.5 g intravenous piperacillin‐tazobactam
Number of subjects: 0
Study 33664081 — intervention group
Group type: COMPARATOR
Intervention: 1‐2 g intravenous cefoxitin
Number of subjects: 0
Study 32815891 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-based administration of the ABILHAND
Number of subjects: 102
Study 32815891 — intervention group
Group type: COMPARATOR
Intervention: Face-to-face administration of the ABILHAND
Number of subjects: 102
Study 35821047 — intervention group
Group type: EXPERIMENTAL
Intervention: Heavyweight Sumo wrestlers
Number of subjects: 54
Study 35821047 — intervention group
Group type: COMPARATOR
Intervention: Middleweight Sumo wrestlers
Number of subjects: 54
Study 34168029 — intervention group
Group type: EXPERIMENTAL
Intervention: Artesunate-mefloquine (AM) - 3-day courses at 6-week intervals
Number of subjects: 0
Study 34168029 — intervention group
Group type: COMPARATOR
Intervention: Praziquantel (PZQ) - single dose of 40 mg/kg
Number of subjects: 0
Study 34168029 — intervention group
Group type: EXPERIMENTAL
Intervention: Artesunate-mefloquine (AM)
Number of subjects: 0
Study 34244991 — intervention group
Group type: EXPERIMENTAL
Intervention: ABRACADABRA reading programme (20 weeks of instruction in grapheme/phoneme knowledge, decoding, and comprehension)
Number of subjects: 516
Study 34244991 — intervention group
Group type: EXPERIMENTAL
Intervention: ABRACADABRA reading programme
Number of subjects: 516
Study 34244991 — intervention group
Group type: COMPARATOR
Intervention: Regular classroom instruction (control group)
Number of subjects: 516
Study 32698957 — intervention group
Group type: EXPERIMENTAL
Intervention: Synbiotic supplement (109 CFU/day) for 8 weeks
Number of subjects: 76
Study 32698957 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 8 weeks
Number of subjects: 76
Study 32856168 — intervention group
Group type: COMPARATOR
Intervention: degarelix
Number of subjects: 403
Study 32856168 — intervention group
Group type: EXPERIMENTAL
Intervention: unidimensional IRT model
Number of subjects: 403
Study 32856168 — intervention group
Group type: EXPERIMENTAL
Intervention: bidimensional IRT model
Number of subjects: 403
Study 36018050 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychodrama sessions added to standard antenatal education
Number of subjects: 150
Study 36018050 — intervention group
Group type: COMPARATOR
Intervention: Routine antenatal education classes (Control)
Number of subjects: 150
Study 34842215 — intervention group
Group type: EXPERIMENTAL
Intervention: Integral Meditation (IM) program consisting of 12 weekly meditation classes after the afternoon shift
Number of subjects: 42
Study 34842215 — intervention group
Group type: EXPERIMENTAL
Intervention: Integral Meditation (IM) program
Number of subjects: 42
Study 32605509 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung cancer screening with low-dose computed tomography
Number of subjects: 45
Study 32605509 — intervention group
Group type: COMPARATOR
Intervention: Health system 1
Number of subjects: 45
Study 32605509 — intervention group
Group type: COMPARATOR
Intervention: Health system 2
Number of subjects: 45
Study 32605509 — intervention group
Group type: COMPARATOR
Intervention: Health system 3
Number of subjects: 45
Study 34928748 — intervention group
Group type: EXPERIMENTAL
Intervention: Cascading Model (CM)
Number of subjects: 100
Study 34928748 — intervention group
Group type: EXPERIMENTAL
Intervention: Learning Collaborative (LC)
Number of subjects: 100
Study 34928748 — intervention group
Group type: EXPERIMENTAL
Intervention: Distance Education (DE)
Number of subjects: 100
Study 35124628 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-incision, single-plate knee surgeries via antero-lateral approach
Number of subjects: 52
Study 35124628 — intervention group
Group type: COMPARATOR
Intervention: Anterior median incisions of the knee for double-plate surgeries
Number of subjects: 52
Study 36184194 — intervention group
Group type: EXPERIMENTAL
Intervention: Essential amino acid enriched meal replacement (EMR)
Number of subjects: 28
Study 36184194 — intervention group
Group type: COMPARATOR
Intervention: Optifast® (Control)
Number of subjects: 28
Study 34582263 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated ototoxicity monitoring (A‐OM) using Oto‐ID mobile audiometer
Number of subjects: 46
Study 34582263 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC) ototoxicity monitoring
Number of subjects: 46
Study 34582263 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated ototoxicity monitoring (A‐OM)
Number of subjects: 46
Study 34582263 — intervention group
Group type: EXPERIMENTAL
Intervention: Both A‐OM and UC
Number of subjects: 46
Study 33397017 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 248
Study 33397017 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic Training (AT)
Number of subjects: 248
Study 33397017 — intervention group
Group type: COMPARATOR
Intervention: Control Group (C)
Number of subjects: 248
Study 34184792 — intervention group
Group type: EXPERIMENTAL
Intervention: Turtle Program
Number of subjects: 151
Study 34184792 — intervention group
Group type: COMPARATOR
Intervention: Cool Little Kids (CLK)
Number of subjects: 151
Study 33941513 — intervention group
Group type: EXPERIMENTAL
Intervention: MV-for-all-policy
Number of subjects: 2778
Study 33941513 — intervention group
Group type: COMPARATOR
Intervention: Restrictive-MV-policy
Number of subjects: 2778
Study 32769526 — intervention group
Group type: EXPERIMENTAL
Intervention: ADSC-CM
Number of subjects: 30
Study 32769526 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 36081227 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (MBI) during pregnancy, comprising usual perinatal care and six digitally guided self-help MBI sessions
Number of subjects: 80
Study 36081227 — intervention group
Group type: COMPARATOR
Intervention: Usual perinatal care (Control group)
Number of subjects: 80
Study 34467631 — intervention group
Group type: EXPERIMENTAL
Intervention: PAC (Physical Activity Consultation) with standard care
Number of subjects: 165
Study 34467631 — intervention group
Group type: EXPERIMENTAL
Intervention: PAC with structured exercise (EGII)
Number of subjects: 165
Study 34467631 — intervention group
Group type: EXPERIMENTAL
Intervention: PAC without structured exercise (EGI)
Number of subjects: 165
Study 34467631 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG - standard care)
Number of subjects: 165
Study 32683992 — intervention group
Group type: EXPERIMENTAL
Intervention: Monopolar dielectric diathermy by emission of radiofrequency (MDR) with 10 sessions over 3 weeks
Number of subjects: 84
Study 32683992 — intervention group
Group type: COMPARATOR
Intervention: Home exercises (10 min daily for 3 weeks)
Number of subjects: 84
Study 32683992 — intervention group
Group type: EXPERIMENTAL
Intervention: Monopolar dielectric diathermy by emission of radiofrequency (MDR)
Number of subjects: 84